Autoimmune Disease News and Research RSS Feed - Autoimmune Disease News and Research

Autoimmune Disease is a condition in which the body recognizes its own tissues as foreign and directs an immune response against them.
AARDA launches autoimmune curriculum for teachers of grades three through eight

AARDA launches autoimmune curriculum for teachers of grades three through eight

Furthering its mission of educating all Americans about autoimmunity and autoimmune disease (AD), the American Autoimmune Related Diseases Association, Inc. (AARDA) has launched the first-of-its kind autoimmune curriculum for teachers of grades three through eight. [More]
New hypothesis about emergence of Parkinson's disease

New hypothesis about emergence of Parkinson's disease

The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells. [More]
BRI scientists receive grant to study new approach to blocking metastatic breast cancer

BRI scientists receive grant to study new approach to blocking metastatic breast cancer

Benaroya Research Institute at Virginia Mason recently received a grant to research how blocking a particular molecule in metastatic breast cancer reduces both the growth of primary tumors and the number of lung metastases. [More]

SWHR co-sponsors National Institutes of Health Forum on microbiome and autoimmunity

The Society for Women's Health Research (SWHR®), the leading voice on the study of the biological differences between women and men, is co-sponsoring the National Institutes of Health (NIH) Forum on the Microbiome and Autoimmunity on Thursday, April 24, at the NIH in Bethesda, Md. [More]

Too much of c-FLIPR protein can trigger autoimmune diseases

So-called c-FLIP proteins inhibit signaling cascades that can lead to apoptosis. This is important temporarily in the response to pathogens to ensure that lymphocytes, a type of immune cells, can proliferate sufficiently. [More]
Virginia Mason wins Healthgrades Outstanding Patient Experience Award for second consecutive year

Virginia Mason wins Healthgrades Outstanding Patient Experience Award for second consecutive year

Virginia Mason was today named a recipient of Healthgrades Outstanding Patient Experience Award for the second consecutive year. This distinction places it among the top 10 percent of hospitals in the nation for patient experience. [More]

New insights provide novel therapeutic approach against cancer

A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes. [More]
EMD Serono collaborates with Pfizer and Broad Institute

EMD Serono collaborates with Pfizer and Broad Institute

EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced they have signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S. The collaboration is focused on the genomic profiling of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) patients. [More]

Patients with autoimmune disease have 3.8-fold increased risk of developing epilepsy

Patients with an autoimmune disease have a 3.8-fold increased risk of developing epilepsy, according to a new population-level study from Boston Children's Hospital based on health insurance claim data. [More]
Idera Pharmaceuticals reports positive top-line results from Phase 2 trial of IMO-8400

Idera Pharmaceuticals reports positive top-line results from Phase 2 trial of IMO-8400

Idera Pharmaceuticals, Inc. today announced positive top-line data from its randomized, double-blind, placebo controlled Phase 2 trial of IMO-8400 in 32 patients with moderate-to-severe plaque psoriasis. [More]
New approach can improve patient outcomes, reduce complications in complex spine surgeries

New approach can improve patient outcomes, reduce complications in complex spine surgeries

A new team approach has improved safety-reducing rates of major complications by two thirds-for complex spinal reconstructive surgery for spinal deformity in adult Group Health patients at Virginia Mason Hospital & Seattle Medical Center. [More]

Virginia Mason's commitment inspires new patient safety measures at hospitals throughout England

Virginia Mason's commitment to safety and quality is helping to inspire new measures aimed at improving patient safety at hospitals throughout England. [More]
STC Life and 97.7 B&H Clinic successfully treat pulmonary fibrosis patient

STC Life and 97.7 B&H Clinic successfully treat pulmonary fibrosis patient

Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully finished mesenchymal stem cell therapy for the pulmonary fibrosis patient who visited Korea from Calgary, Canada. [More]
One person's unique ability provides key insights into immune response to fight HIV

One person's unique ability provides key insights into immune response to fight HIV

One person's unique ability to fight HIV has provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to findings reported by a team that includes Duke Medicine scientists. [More]
Kamada initiates Phase 2/3 clinical trial of Glassia to treat pediatric patients with T1D

Kamada initiates Phase 2/3 clinical trial of Glassia to treat pediatric patients with T1D

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the initiation of a Phase 2/3 clinical trial of Glassia®, the Company's proprietary human Alpha-1 Antitrypsin (AAT), to treat newly diagnosed pediatric patients with type 1 diabetes (T1D). [More]
People suffering from schizophrenia at greater risk of developing autoimmune diseases

People suffering from schizophrenia at greater risk of developing autoimmune diseases

​Researchers have long known that people with autoimmune diseases, such as hepatitis, type 1 diabetes, multiple sclerosis and psoriasis, are at greater risk of developing schizophrenia. [More]
Researchers identify effective target for human autoimmune disease

Researchers identify effective target for human autoimmune disease

Researchers at King's College London have identified a new gene (PIM1), which could be an effective target for innovative treatments and therapies for the human autoimmune disease, psoriasis. [More]
Psoriasis registry: an interview with Dr. Andrew D. Robertson, Chief Scientific and Medical Officer, National Psoriasis Foundation

Psoriasis registry: an interview with Dr. Andrew D. Robertson, Chief Scientific and Medical Officer, National Psoriasis Foundation

Psoriasis is the most common autoimmune disease in the US, affecting 2 to 3% of all Americans. What causes psoriasis in any one individual will stem from a mixture of their genetic background and their environment. [More]
Vitamin A may help keep immune system under control for autoimmune and transplant patients

Vitamin A may help keep immune system under control for autoimmune and transplant patients

The same form of Vitamin A used by teenagers to combat acne might offer benefits that are more than skin deep. That's because an international team of researchers have found that it may also help keep the immune system under control for people with autoimmune disorders or those who have received transplants. [More]
New technique enables visualisation of human autoimmune disease in animal models

New technique enables visualisation of human autoimmune disease in animal models

Researchers at Lund University have managed to develop a technique whereby they can study the inflammatory process that takes place in the pancreas during the natural development of type 1 diabetes, allowing for real time and repeated non-invasive imaging of individual islets of Langerhans. [More]